Morfina Cloridrato S.A.L.F. (Morphine Hydrochloride Trihydrate)

Morphine hydrochloride, the active ingredient in Morfina Cloridrato S.A.L.F., is an opioid analgesic presented as an injectable solution for epidural, intramuscular, and intravenous use. It provides analgesia for severe acute, postoperative, cancer‑related, and chronic severe pain in adult patients.

GNH USA supplies Morfina Cloridrato S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine hydrochloride is an opioid analgesic that relieves pain by activating the μ‑opioid receptor pathway. - Severe acute pain: delivers rapid relief of intense pain episodes. - Postoperative pain: reduces discomfort following surgical procedures. - Cancer pain: alleviates persistent pain associated with malignant disease. - Chronic severe pain: helps control long‑term severe pain when other therapies are insufficient.

Morphine hydrochloride may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness or unsteadiness. - Sweating: excessive perspiration unrelated to temperature. - Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Hypotension: significant drop in blood pressure causing faintness. - Anaphylaxis: severe allergic reaction with rash, swelling, and airway compromise. - Adrenal insufficiency: impaired cortisol production leading to fatigue and weakness. - Seizures: rare occurrence of convulsive episodes.

When using morphine hydrochloride, careful monitoring and specific safety measures are essential. - Assess pain level: evaluate severity before initiating therapy. - Monitor respiration: watch for signs of respiratory depression, especially after dose changes. - Adjust for organ impairment: modify dosing in patients with renal or hepatic dysfunction. - Avoid concurrent CNS depressants: limit use with benzodiazepines, alcohol, or similar agents. - Use cautiously in the elderly: increased sensitivity to sedative and respiratory effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Morphine hydrochloride can interact with several drug classes, influencing its safety and efficacy.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - CNS depressants (e.g., benzodiazepines): heightened risk of profound sedation and respiratory compromise. - MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): increase morphine plasma concentrations. - CYP3A4 inducers (e.g., rifampin): reduce morphine effectiveness. - Diuretics: may exacerbate hypotension when combined with morphine.